TSHA compared with QURE: revenue, margins and what each company keeps, and the suppliers and customers both name

TSHATaysha Gene Therapies, Inc.

Mkt capRevenueRevenue

QUREuniQure N.V.

Mkt capRevenueRevenue

Compare

TSHATaysha Gene Therapies, Inc.

QUREuniQure N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TSHA 10

ABEOAbeonasupplier

—The Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Centerunlistedsupplier

—The Board of Regents of the University of Texas System on behalf of UT Southwesternunlistedsupplier

—University of North Carolina at Chapel Hillunlistedsupplier

6 more · TSHA chain ›

Shared 0

No shared counterparties.

Only QURE 9

FDMT4D Molecular Therapeuticssupplier

RGNXRegenxbiosupplier

—Apic Biounlistedsupplier

—Cold Spring Harbor Laboratory

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

5 more · QURE chain ›

TSHATaysha Gene Therapies, Inc.

Revenue$5MQ4 FY25Revenue$8MFY24

QUREuniQure N.V.

Revenue$5MQ3 FY26Revenue$16MFY25

Compare

TSHATaysha Gene Therapies, Inc.

QUREuniQure N.V.

Price

Q4 FY25$5M

Revenue

$5MQ3 FY26

FY24$8M

Revenue

$16MFY25

TSHAvsQURE